The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Click play to stream The Final Frontier at no cost

Trent Kamke Biography and Net Worth

Senior Vice President, Operations of LeMaitre Vascular

Trent G. Kamke has served as our Senior Vice President, Operations since 2005. Mr. Kamke joined us in 1997 as Quality Assurance Manager. From 1999 to 2005, Mr. Kamke served as our Vice President, Operations. Prior to joining us in 1997, Mr. Kamke was employed by Haemonetics Corporation, which designs, manufacturers, and markets automated blood processing equipment. Mr. Kamke received a B.A. in Physics from Colby College and a B.E. from the Thayer School of Engineering at Dartmouth College. Provided by Tagnifi.

What is Trent G. Kamke's net worth?: The estimated net worth of Trent G. Kamke is at least $463,032.72 as of August 5th, 2024. Mr. Kamke owns 4,561 shares of LeMaitre Vascular stock worth more than $463,033 as of November 14th. This net worth estimate does not reflect any other assets that Mr. Kamke may own. Additionally, Mr. Kamke receives a salary of $445,380.00 as Senior Vice President, Operations at LeMaitre Vascular. Learn More about Trent G. Kamke's net worth.
How old is Trent G. Kamke?: Mr. Kamke is currently 53 years old. There are 9 older executives and no younger executives at LeMaitre Vascular. The oldest executive at LeMaitre Vascular is Dr. George D. LeMaitre, Founder and Chairman of Scientific Advisory Board, who is 90 years old. Learn More on Trent G. Kamke's age.
What is Trent G. Kamke's salary?: As the Senior Vice President, Operations of LeMaitre Vascular, Inc., Mr. Kamke earns $445,380.00 per year. There are 3 executives that earn more than Mr. Kamke. The highest earning executive at LeMaitre Vascular is Mr. George W. LeMaitre, Chairman & CEO, who commands a salary of $1,120,000.00 per year. Learn More on Trent G. Kamke's salary.
How do I contact Trent G. Kamke?: The corporate mailing address for Mr. Kamke and other LeMaitre Vascular executives is 63 SECOND AVENUE, BURLINGTON MA, 01803. LeMaitre Vascular can also be reached via phone at (781) 221-2266. Learn More on Trent G. Kamke's contact information.
Has Trent G. Kamke been buying or selling shares of LeMaitre Vascular?: Trent G. Kamke has not been actively trading shares of LeMaitre Vascular over the course of the past ninety days. Most recently, Trent G. Kamke sold 182 shares of the business's stock in a transaction on Monday, August 5th. The shares were sold at an average price of $81.82, for a transaction totalling $14,891.24. Following the completion of the sale, the insider now directly owns 4,561 shares of the company's stock, valued at $373,181.02. Learn More on Trent G. Kamke's trading history.
Who are LeMaitre Vascular's active insiders?: LeMaitre Vascular's insider roster includes Trent Kamke (Senior Vice President, Operations), George Lemaitre (CEO), Joseph Pellegrino, Jr. (CFO), David Roberts (Director), and John Roush (Director). Learn More on LeMaitre Vascular's active insiders.
Are insiders buying or selling shares of LeMaitre Vascular?: In the last twelve months, insiders at the medical instruments supplier sold shares 15 times. They sold a total of 291,875 shares worth more than $20,789,758.71. The most recent insider tranaction occured on August, 13th when Director David B Roberts sold 3,063 shares worth more than $251,380.41. Insiders at LeMaitre Vascular own 10.8% of the company. Learn More about insider trades at LeMaitre Vascular.
Information on this page was last updated on 8/13/2024.

Trent G. Kamke Insider Trading History at LeMaitre Vascular

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2024	Sell	182	$81.82	$14,891.24	4,561
3/3/2023	Sell	6,414	$50.94	$326,729.16	3,791
3/2/2022	Sell	7,929	$48.22	$382,336.38
6/15/2021	Sell	876	$58.01	$50,816.76	13,083
6/10/2021	Sell	3,308	$55.00	$181,940.00	12,606
3/1/2021	Sell	10,004	$51.28	$513,005.12	3,735
11/24/2020	Sell	18,609	$39.99	$744,173.91	2,838
7/24/2020	Sell	13,804	$33.00	$455,532.00	21,558
2/22/2019	Sell	16,604	$29.63	$491,976.52	19,857
5/29/2018	Sell	1,365	$32.66	$44,580.90	20,424
5/25/2018	Sell	12,368	$32.83	$406,041.44	20,424
5/24/2017	Sell	15,780	$30.28	$477,818.40	31,341
6/3/2016	Sell	2,510	$15.00	$37,650.00	15,573
5/25/2016	Sell	1,524	$15.25	$23,241.00	18,183
5/23/2016	Sell	16,465	$15.02	$247,304.30	12,204
5/17/2016	Sell	2,400	$15.51	$37,224.00	20,492
5/5/2016	Sell	3,327	$16.10	$53,564.70	22,692
11/13/2014	Sell	1,100	$7.15	$7,865.00
8/12/2013	Sell	2,000	$6.90	$13,800.00
8/8/2013	Sell	2,000	$6.83	$13,660.00

Trent G. Kamke Buying and Selling Activity at LeMaitre Vascular

LeMaitre Vascular Company Overview

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $101.52

$101.15

$103.52

50 Day Range

MA: $91.56

$85.64

$105.50

2 Week Range

Now: $101.52

$50.42

$106.49

Volume

82,539 shs

Average Volume

124,613 shs

Market Capitalization

$2.28 billion

P/E Ratio

55.48

Dividend Yield

0.62%

Beta

0.89

Nvidia’s world of pain awaits

From Porter & Company | Ad

Click play to stream The Final Frontier at no cost

Trent Kamke Biography and Net Worth

What is Trent G. Kamke's net worth?

How old is Trent G. Kamke?

What is Trent G. Kamke's salary?

How do I contact Trent G. Kamke?

Has Trent G. Kamke been buying or selling shares of LeMaitre Vascular?

Who are LeMaitre Vascular's active insiders?

Are insiders buying or selling shares of LeMaitre Vascular?